HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections.

Abstract
Identification of bacteria in clinical samples is fundamental to combating infections. Modern molecular genetic approaches exploit nucleic acids signals from clinical samples. However, DNA-derived signals can originate from nonviable bacterial cells and, therefore, generate data that could be misinterpreted. Terminal restriction fragment length polymorphism profiling of cystic fibrosis sputum samples was combined with propidium monoazide (PMA) photo-induced cross-linking. PMA is highly membrane impermeant and is excluded from viable bacteria but readily penetrates dead cells. Exposure to a light source renders DNA in permeable cells incapable of contributing to polymerase chain reaction. PMA treatment was shown to effectively prevent dead bacteria, spiked into sputum samples, from contributing to profiles. Comparison of treated and untreated clinical samples indicated that dead bacterial cells significantly bias untreated profiles. These findings highlight the significant contribution that nonviable bacteria can make to DNA-based diagnostic analysis of clinical samples while providing a simple and effective means of avoiding such bias.
AuthorsGeraint B Rogers, Franziska A Stressmann, Garrit Koller, Thomas Daniels, Mary P Carroll, Kenneth D Bruce
JournalDiagnostic microbiology and infectious disease (Diagn Microbiol Infect Dis) Vol. 62 Issue 2 Pg. 133-41 (Oct 2008) ISSN: 0732-8893 [Print] United States
PMID18692341 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Azides
  • Cross-Linking Reagents
  • DNA, Bacterial
  • RNA, Ribosomal, 16S
  • Propidium
Topics
  • Adult
  • Azides (metabolism, pharmacology)
  • Cell Membrane Permeability
  • Cross-Linking Reagents
  • Cystic Fibrosis (diagnosis, microbiology)
  • DNA, Bacterial (genetics)
  • Gram-Negative Bacteria (drug effects, genetics, growth & development)
  • Humans
  • Microbial Viability
  • Microscopy, Fluorescence
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Propidium (metabolism, pharmacology)
  • RNA, Ribosomal, 16S (genetics)
  • Respiratory Tract Infections (diagnosis, microbiology)
  • Sputum (microbiology)
  • Staphylococcus aureus (drug effects, genetics, growth & development)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: